Spots Global Cancer Trial Database for localized resectable adult primary liver cancer
Every month we try and update this database with for localized resectable adult primary liver cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer | NCT00274885 | Cancer | oxaliplatin management of t... | 18 Years - | National Cancer Institute (NCI) | |
| Iodine I 131 Ethiodized Oil in Preventing Recurrent Cancer in Patients Who Have Undergone Treatment for Liver Cancer | NCT00870558 | Liver Cancer | ethiodized oil iodine I 131 et... | 18 Years - | National Cancer Institute (NCI) | |
| BMS-247550 in Treating Patients With Liver or Gallbladder Cancer | NCT00023946 | Adult Primary C... Adult Primary H... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Localized Extra... Localized Gallb... Localized Resec... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga... | ixabepilone laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Celecoxib and Erlotinib in Treating Patients With Liver Cancer | NCT00293436 | Liver Cancer | celecoxib erlotinib hydro... adjuvant therap... | 18 Years - | University of California, San Francisco | |
| Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer | NCT00081094 | Liver Cancer | 18F-Fluorodeoxy... 11Carbon-Acetat... | 18 Years - | Washington University School of Medicine | |
| Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer | NCT01009801 | Liver Cancer | doxorubicin-elu... everolimus placebo | 18 Years - | Swiss Group for Clinical Cancer Research | |
| Celecoxib and Erlotinib in Treating Patients With Liver Cancer | NCT00293436 | Liver Cancer | celecoxib erlotinib hydro... adjuvant therap... | 18 Years - | University of California, San Francisco | |
| Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer | NCT00363584 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | capecitabine clinical observ... adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
| Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer | NCT00436410 | Adrenocortical ... Breast Cancer Colorectal Canc... Gastrointestina... Kidney Cancer Liver Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Sarcoma | colloidal gold-... electron micros... pharmacological... conventional su... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer | NCT01624285 | Adult Primary H... Localized Resec... Localized Unres... Recurrent Adult... | sorafenib tosyl... placebo laboratory biom... | 19 Years - | Jonsson Comprehensive Cancer Center | |
| BMS-247550 in Treating Patients With Liver or Gallbladder Cancer | NCT00023946 | Adult Primary C... Adult Primary H... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Localized Extra... Localized Gallb... Localized Resec... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga... | ixabepilone laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Radioactive Iodine in Treating Patients Who Have Undergone Surgery for Liver Cancer | NCT00027768 | Liver Cancer | adjuvant therap... iodine I 131 et... | 17 Years - | National Cancer Institute (NCI) | |
| EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer | NCT00087191 | Advanced Adult ... Carcinoma of th... Fallopian Tube ... Gastrointestina... Localized Extra... Localized Gallb... Localized Gastr... Localized Resec... Localized Unres... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Primary Periton... Recurrent Adult... Recurrent Adult... Recurrent Colon... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Small... Recurrent Uteri... Regional Gastro... Small Intestine... Small Intestine... Small Intestine... Stage 0 Non-sma... Stage I Adult S... Stage I Colon C... Stage I Gastric... Stage I Non-sma... Stage I Ovarian... Stage I Ovarian... Stage I Pancrea... Stage I Rectal ... Stage I Uterine... Stage II Adult ... Stage II Colon ... Stage II Gastri... Stage II Non-sm... Stage II Ovaria... Stage II Ovaria... Stage II Pancre... Stage II Rectal... Stage II Uterin... Stage III Adult... Stage III Colon... Stage III Gastr... Stage III Ovari... Stage III Ovari... Stage III Pancr... Stage III Recta... Stage III Uteri... Stage IIIA Non-... Stage IIIB Non-... Stage IV Adult ... Stage IV Colon ... Stage IV Gastri... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Rectal... Stage IV Uterin... Unresectable Ex... Unresectable Ga... | EF5 motexafin lutet... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Sorafenib Tosylate in Treating Patients With Liver Cancer Who Have Undergone a Liver Transplant | NCT00844168 | Adult Primary H... Advanced Adult ... Localized Resec... Localized Unres... Recurrent Adult... | sorafenib tosyl... laboratory biom... | 18 Years - | University of Washington | |
| Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer | NCT00363584 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | capecitabine clinical observ... adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
| 3-Tesla MRI Response to TACE in HCC (Liver Cancer) | NCT02057874 | Adult Primary H... Advanced Adult ... Localized Resec... Localized Unres... Stage A Adult P... Stage B Adult P... | 3 Tesla Magneti... Magnevist® (Int... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer | NCT00003296 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | filgrastim pegylated lipos... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver Cancer | NCT00276705 | Liver Cancer | cisplatin cyclophosphamid... doxorubicin hyd... thalidomide adjuvant therap... conventional su... neoadjuvant the... | - 29 Years | National Cancer Institute (NCI) | |
| Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen | NCT00016380 | Cancer | dexamethasone ondansetron quality-of-life... | 16 Years - 120 Years | Canadian Cancer Trials Group | |
| Sorafenib Tosylate in Treating Patients With Liver Cancer That Can Be Removed by Surgery | NCT01182272 | Liver Cancer | sorafenib tosyl... laboratory biom... neoadjuvant the... therapeutic con... | 18 Years - | National Cancer Institute (NCI) | |
| Sorafenib Tosylate in Treating Patients With Liver Cancer That Can Be Removed by Surgery | NCT01182272 | Liver Cancer | sorafenib tosyl... laboratory biom... neoadjuvant the... therapeutic con... | 18 Years - | National Cancer Institute (NCI) | |
| National Registry and Blood Bank of Patients With Liver Cancer | NCT00482365 | Liver Cancer | biologic sample... medical chart r... Patient intervi... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Vaccine Therapy in Treating Patients With Stage II, Stage IIIA, Stage IIIB, or Stage IVA Liver Cancer | NCT00093548 | Liver Cancer | alpha fetoprote... alpha fetoprote... sargramostim pl... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer | NCT01009801 | Liver Cancer | doxorubicin-elu... everolimus placebo | 18 Years - | Swiss Group for Clinical Cancer Research | |
| Sorafenib Tosylate in Treating Patients With Liver Cancer That Can Be Removed by Surgery | NCT01182272 | Liver Cancer | sorafenib tosyl... laboratory biom... neoadjuvant the... therapeutic con... | 18 Years - | National Cancer Institute (NCI) | |
| Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer | NCT01009801 | Liver Cancer | doxorubicin-elu... everolimus placebo | 18 Years - | Swiss Group for Clinical Cancer Research | |
| Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer | NCT00003296 | Extrahepatic Bi... Gallbladder Can... Liver Cancer | filgrastim pegylated lipos... | 18 Years - | National Cancer Institute (NCI) | |
| Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen | NCT00016380 | Cancer | dexamethasone ondansetron quality-of-life... | 16 Years - 120 Years | Canadian Cancer Trials Group | |
| SCH 66336 With or Without Gemcitabine Followed by Surgery Compared With Surgery Alone in Treating Patients With Primary Liver Cancer | NCT00020774 | Liver Cancer | gemcitabine hyd... lonafarnib conventional su... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| BMS-247550 in Treating Patients With Liver or Gallbladder Cancer | NCT00023946 | Adult Primary C... Adult Primary H... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Localized Extra... Localized Gallb... Localized Resec... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga... | ixabepilone laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer | NCT00238160 | Localized Resec... Stage III Child... | cisplatin fluorouracil adjuvant therap... chemotherapy conventional su... hepatic arteria... surgery | - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Liver Cancer | NCT00005629 | Liver Cancer | AFP gene hepato... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Cancer | NCT00030511 | Extrahepatic Bi... Liver Cancer | fluorouracil conventional su... radiation thera... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Iodine I 131 Ethiodized Oil in Preventing Recurrent Cancer in Patients Who Have Undergone Treatment for Liver Cancer | NCT00870558 | Liver Cancer | ethiodized oil iodine I 131 et... | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Liver Cancer | NCT00005629 | Liver Cancer | AFP gene hepato... | 18 Years - | Jonsson Comprehensive Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
